The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 511, doi. 10.1111/dom.16041
- By:
- Publication type:
- Article